BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14634058)

  • 21. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
    Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
    Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD28 regulates glucocorticoid-induced TNF receptor family-related gene expression on CD4+ T cells via IL-2-dependent mechanisms.
    Kohm AP; Podojil JR; Williams JS; McMahon JS; Miller SD
    Cell Immunol; 2005 May; 235(1):56-64. PubMed ID: 16137665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of IL-13 receptor alpha 1 expression and signaling on human tonsillar B-lymphocyte subsets.
    Hajoui O; Zheng H; Guay J; Letuve S; Fawaz LM; Mazer BD
    J Allergy Clin Immunol; 2007 Dec; 120(6):1425-32. PubMed ID: 17761275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses.
    Chan KW; Hopke CD; Krams SM; Martinez OM
    J Immunol; 2002 Aug; 169(4):1784-91. PubMed ID: 12165500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma.
    Jones D; Fletcher CD; Pulford K; Shahsafaei A; Dorfman DM
    Blood; 1999 May; 93(10):3487-93. PubMed ID: 10233901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge.
    Bekiaris V; Gaspal F; Kim MY; Withers DR; Sweet C; Anderson G; Lane PJ
    Eur J Immunol; 2009 Aug; 39(8):2120-5. PubMed ID: 19609980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD30 ligation differentially affects CXCR4-dependent HIV-1 replication and soluble CD30 secretion in non-Hodgkin cell lines and in gamma delta T lymphocytes.
    Biswas P; Mantelli B; Delfanti F; Ferrarini M; Poli G; Lazzarin A
    Eur J Immunol; 2003 Nov; 33(11):3136-45. PubMed ID: 14579282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of OX40-mediated co-stimulation in T-cell activation and survival.
    Redmond WL; Ruby CE; Weinberg AD
    Crit Rev Immunol; 2009; 29(3):187-201. PubMed ID: 19538134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of tumor necrosis factor superfamily members CD30 and OX40 abrogates disease activity in murine immune-mediated glomerulonephritis.
    Artinger K; Kirsch AH; Mooslechner AA; Cooper DJ; Aringer I; Schuller M; Schabhüttl C; Klötzer KA; Schweighofer K; Eller P; Yagita H; Illert AL; Rosenkranz AR; Lane PJ; Eller K
    Kidney Int; 2021 Aug; 100(2):336-348. PubMed ID: 33785369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory.
    Gaspal FM; Kim MY; McConnell FM; Raykundalia C; Bekiaris V; Lane PJ
    J Immunol; 2005 Apr; 174(7):3891-6. PubMed ID: 15778343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The TNF-TNFR Family of Co-signal Molecules.
    So T; Ishii N
    Adv Exp Med Biol; 2019; 1189():53-84. PubMed ID: 31758531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression in the Gitr locus is regulated by NF-κB and Foxp3 through an enhancer.
    Tone Y; Kidani Y; Ogawa C; Yamamoto K; Tsuda M; Peter C; Waldmann H; Tone M
    J Immunol; 2014 Apr; 192(8):3915-24. PubMed ID: 24634496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical synergy of CD30 and OX40 signals in CD4 T cell homeostasis and Th1 immunity to Salmonella.
    Gaspal F; Bekiaris V; Kim MY; Withers DR; Bobat S; MacLennan IC; Anderson G; Lane PJ; Cunningham AF
    J Immunol; 2008 Mar; 180(5):2824-9. PubMed ID: 18292503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OX40 signaling favors the induction of T(H)9 cells and airway inflammation.
    Xiao X; Balasubramanian S; Liu W; Chu X; Wang H; Taparowsky EJ; Fu YX; Choi Y; Walsh MC; Li XC
    Nat Immunol; 2012 Oct; 13(10):981-90. PubMed ID: 22842344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD30
    Lam JH; Hong M; Koo SL; Chua CWL; Lim KL; Wee F; Wan WK; Leow WQ; Yeo JG; Tan IBH; Yeong J; Lim TKH; Lim TS
    Cancer Immunol Immunother; 2021 Aug; 70(8):2353-2365. PubMed ID: 33527196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OX40: Structure and function - What questions remain?
    Willoughby J; Griffiths J; Tews I; Cragg MS
    Mol Immunol; 2017 Mar; 83():13-22. PubMed ID: 28092803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abrogation of CD30 and OX40 signals prevents autoimmune disease in FoxP3-deficient mice.
    Gaspal F; Withers D; Saini M; Bekiaris V; McConnell FM; White A; Khan M; Yagita H; Walker LS; Anderson G; Lane PJ
    J Exp Med; 2011 Aug; 208(8):1579-84. PubMed ID: 21788408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.